Clinical Trials Directory

Trials / Conditions / Urethral Neoplasms

Urethral Neoplasms

7 registered clinical trials studyying Urethral Neoplasms — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingAgnostic Therapy in Rare Solid Tumors
NCT06638931
Instituto do Cancer do Estado de São PauloPhase 2
TerminatedA Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
NCT03288545
Astellas Pharma Global Development, Inc.Phase 1 / Phase 2
CompletedA Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
NCT03219333
Astellas Pharma IncPhase 2
TerminatedLCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
NCT02612194
Wake Forest University Health SciencesPhase 2
CompletedCabozantinib for Advanced Urothelial Cancer
NCT01688999
National Cancer Institute (NCI)Phase 2
CompletedGemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other So
NCT01352962
National Cancer Institute (NCI)Phase 1
CompletedTOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the Uroth
NCT00077688
Achieve Life SciencesPhase 2